A B S T R A C T Our purpose was to determine whether exposure to a realistic concentration of nitrogen dioxide (NO2) could increase the bronchial sensitivity of asthmatic patients to bronchoconstrictor agents. We established dose-response curves for changes in specific airway resistance (SRaw) in response to aerosolized carbachol in 20 asthmatics after each had spent 1 h in an exposure chamber breathing on one occasion unpolluted air and on a separate occasion 0.1 ppm N02: sequence of exposures to unpolluted air and to low levels of NO2 were randomized in a single-blind fashion. N02 induced a slight but significant increase in initial SRa. and enhanced the bronchoconstrictor effect of carbachol in 13 subjects: curves were shifted to the left and the mean dose of carbachol producing a twofold increase in initial SRaw was decreased from 0.66 mg to 0.36 mg (P < 0.001). In contrast, NO2 neither modified the initial SRaw nor the bronchoconstrictor effect of carbachol in seven subjects. In 4 out of the 20 subjects, exposure to a higher concentration of NO (0.2 ppm) yielded variable results.
INTRODUCTION
Epidemiological studies have suggested there is a relationship between air pollution and the prevalence and severity of asthma as well as chronic pulmonary diseases in general (for review see references [1] [2] [3] [4] . However, the role of air pollution is still questioned since in ex-periments with controlled exposures, air pollutants exert a detectable effect on lung function only at concentrations that exceed those commonly observed in urban polluted atmosphere. To our knowledge very few of these laboratory studies (5-7) have been performed with asthmatics. These few have demonstrated that asthmatics reacted to smaller doses of pollutants than normal subjects, but the doses used were still higher than those usually encountered in the atmosphere.
In this study we have investigated the direct bronchomotor effect of realistic concentrations of nitrogen dioxide (NO2), one of the major air pollutants, in a group of asthmatics. We have also measured the bronchial sensitivity to carbachol before and after NO exposure in order to establish whether N02 could make the airways "hyperreactive." METHODS Subjects. 20 asthmatics volunteered for this study (NO2 group, Table I ). All were outpatients, suffering from slight to mild asthma. They were studied during symptom-free periods and received no symptomatic medication for at least 24 h beforehand. None of these subjects was undergoing long-term steroid therapy and all of them lived in an urban area.
Airway resistance (Ra., ) 1 measurements. We recorded simultaneously Raw and thoracic gas volume (TGV; 8) with a constant volume body plethysmograph (DR-8 amplifier-recorder, Electronics for Medicine, Inc., White Plains, N. Y.). The subject panted at a frequency of 2 cycles/s and a flow rate of 0.5 liter/s (9) . The results were expressed as specific airway resistance, SRaw = Raw X TGV, (expressed in centimeters of water X second) which is preferable to the use of specific airway conductance (10) . NO 246±18 ,ug/m3 and decreased regularly: -10o for the second interval, -9% for the third interval, and -16% for the fourth interval. The average concentration during the hour exposure was 210 ,ug/m3, which is approximatively 0.1 ppm. In some cases a higher dose of NO2 was used:
average concentration of 488 /Ag/mn (slightly over 0.2 ppm).
None of the subjects reported having detected a particular odor due to the gas. Carbachol dose-response curves. After measurement of basal SR.w (mean of five determinations) a dose-response curve was established for each subject by using a 0.1%o (wt/vol) nebulized solution of carbachol (Merck A.G. Inc., Darmstadt, West Germany) in 0.9% saline and changes in SR.w as an index of response. An aerosolizer (Gauthier, Paris; particle size of 0.1-5 Aum) delivering 0.0232 mg of carbachol base per liter of air, was used to fill a spirometer bell with fresh aerosol. A two-way valve allowed inspiration from the spirometer and expiration outside the room. The subject was instructed to make from one to five inspirations of a fixed volume of aerosol (860 ml) and to hold his breath for 4 s after each inspiration to ensure a large particle retention (12) . The carbachol inhalation of one to five 860-ml volumes represented a quantity of carbachol base varying from 0.02 to 0.1 mg. Because of inaccuracy inherent in any aerosol inhalation technique, the doses of carbachol actually deposited in the airways are probably different from those administered. However, since the inhalation technique was standardized, the error was thought to be constant throughout the different tests. After each carbachol inhalation SR.w was measured (mean of three determinations). The sequence-filling the spirometer with fresh aerosol, carbachol inhalation, and SRaw determination-lasted about 2-4 min and was repeated until at least a 100% increase of initial SRaw was obtained. This procedure yielded a gradual increase in SRaw, and the observer could easily modulate the intensity of the bronchial response by adjusting the magnitude of the carbachol inhalation. Since the progressive increase of SRaw with repetitive carbachol inhalations was not interrupted by allowing a return to base-line values between each carbachol inhalation and since carbachol is not metabolized by acetylcholinesterase, the dose-response curves obtained in this way were considered to be of the cumulative type (13).
Experimental protocols. Each subject was tested according to two different randomized protocols, between 2 and 6 p.m. on two separate days, with a 1-wk interval. Each test was run as follows: After determination of basal SRaw the subject was taken to the exposure room. The subject was left free to breathe either through the nose or mouth and remained seated in the room for 1 h. Then, new determinations of SRaw were made and carbachol doseresponse curves were obtained as described. At one occasion, NOa was present (NO2 test) in the air within the exposure room, whereas for the control test performed on a separate day, it was absent. The subject was unaware of the presence or absence of NO2. All 20 subjects of the NO, group had a control test and a NO2 test with 0.1 ppm NO2. by 1 and 2 wk, respectively). Four subjects (subjects 2, 8, 13, 20) , in addition to the 0.1 ppm NO2 test, underwent a test using 0.2 ppm NO0. In these cases, the order of the tests was also randomized.
With each subject serving as his own control, we compared the carbachol dose-response curves obtained on the control test to those obtained on the NO2 test to determine if NO2 changed the bronchial sensitivity to carbachol. To quantify the results we calculated from the curves the doses of carbachol causing a 100%o increase of initial SR.w (Dioo).
Reproducibility of carbachol dose-response curves. To assess the spontaneous variability of carbachol dose-response curves we tested another group of 10 asthmatics (control group) with clinical histories and functional values similar to those of the subjects in the NO group. Two control carbachol dose-response curves were performed at a 1-wk interval and the D1no values were calculated from the curves.
In addition, two subjects (subjects 5 and 16) of the preceding group had two control tests. Table II shows that the D10 was reproducible and that no systematic error appeared attributable to repetition of the procedure.
RESULTS
Individual results are shown in Fig. 1 . As expected, the bronchial sensitivity to carbachol determined in the control test was variable among the individuals examined. Exposure to 0.1 ppm of NO2 markedly increased the basal value of SR.w in only three subjects (subjects 3, 6, and 16). In others, SRaw was marginally increased, if at all. The effect of 0.1 ppm of NO2 on the bronchial sensitivity to carbachol was also variable. In some subjects no clear change could be detected whereas in others the effect of carbachol on SRa., was enhanced. Doseresponse curves were shifted to the left with a resulting decrease in the Do, and the slopes were usually steeper than the slopes of control dose-response curves. In subject 16, the enhancement of the carbachol effect by 0.1 ppm NO0 was reproduced on two occasions. When a concentration of 0.2 ppm of NO2 was used it appears from Fig. 1 that this higher dose was (a) no more effective than 0.1 ppm in increasing the carbachol effect in subjects 2 and 8, (b) as effective as 0.1 ppm in subject 13, and (c) more effective in subject 20, in whom the Dioo was reduced from 0.94 to 0.42 mg. Exposure to NO did not change the TGV. Since the degree of bronchial obstruction produced by carbachol inhalation was similar before and after NO0 the accompanying increase in TGV was also similar in both occasions. Fig. 2 shows the changes in Duoe, for each subject, observed in this group of asthmatics (NO2 group) after exposure to 0.1 ppm NO2 as compared to the spontaneous changes observed in the control group. For the NO2 group, "test 1" refers to the Dioo before NO0 and "test 2" to the Duso after NO2. For the control group, the largest Dioo observed was chosen as test 1 and the smallest value as test 2 since the expected change in Die, after NO2 exposure was a decrease. It appears from the figure that the spontaneous decreases in Dloo observed on two different tests in the control group were smaller than 20%. Seven asthmatics of the NO2 group, being inside this 20% limit, were classified as "NO2-nonresponders" (subjects 2, 5, 7-9, 11, and 12), whereas 13 subjects having a decrease of more than 20% in Dioe after NO exposure were classified as "NO2-responders" (subjects 1, 3, 4, 6, 10, and 13-20). ences appeared between the two groups as regard to their physical characteristics (age, sex), the clinical history (duration, severity of asthma), the etiology of asthma (extrinsic or intrinsic), and the smoking history of the subjects tested.
DISCUSSION
The present results demonstrate that, in sBfe asthmatics, exposure to low concentrations of NO catues a moderate bronchial obstruction and markedly increases their bronchial sensitivity to a bronchoconstrictor agent. Such an increase in bronchial sensitivity has been reported in animals with larger doses of NO or other pollutants (14) (15) .
So far the mechanism underlying this phenomenon is unclear and several hypotheses are conceivable. Ra, is mostly determined by bronchial caliber, which in turn is determined by both bronchial factors and extrabronchial factors such as elastic recoil forces. NO could, therefore, alter one of these elements with the same resulting effect. NO2 has been reported as causing emphysema (see references 2 and 3) and consequently, a change in lung elastic recoil. However, this is unlikely to have happened in our study since these changes appeared after long-term exposure. Short-term exposure to NO2 could increase the bronchial tone by releasing histamine, as suggested by Nieding and Krekeler (16), or by stimulating the lung irritant receptors (17) . Vagally mediated bronchoconstriction has been demonstrated for S02 (18) , and the irritant receptors are thought to be hypersensitive in asthma (5) . Such an increase in bronchial tone by N02 would explain the enhanced effect of carbachol since interaction between a bronchoconstrictor agent and increased airway tone would result in a potentiation of the effect of the bronchoconstrictor agent (19) .
The enhancement of bronchial sensitivity by NOs was variable among individuals in the NO.-responder group. This NO2 effect seems reproducible as observed in subject 16. The effect of NO does not appear to be necessarily related to the dose since a dose-effect relationship (21) . Differences in NO2 sensitivity between asthmatics could also be due to intrinsic individual variations in bronchial responses. Indeed such variations in NO effect were reported in normal subjects (22) . If our previous hypothesis concerning critical threshold of NO2 is correct, we can assume that the first critical threshold was reached neither with 0.1 ppm of NO2 for the NO0-nonresponders (seven subjects) nor with 0.2 ppm of N02 in two subjects of this group. However, an alternative explanation is to consider that the NO-nonresponders are not NO2 insensitive but rather NO2 hypersensitive. Thus, these subjects were exposed to urban concentrations of NO2 and one can assume they had already reached the first threshold and were already "carbachol sensitized." In these conditions it is possible that exposure to 0.1 ppm of NO2 had no further effect if the second threshold of sensitization was not reached. This hypothesis is supported by the fact that the NO2-nonresponders were, on average, more obstructive and more sensitive to carbachol on the control test than the N02-responders.
Considering the practical consequences of our findings, we suggest that the incidence and severity of asthmatic attacks would be higher in areas with a polluted atmosphere, at least for some very sensitive subjects. 
